Every year, respiratory syncytial virus (RSV) poses a serious threat to the health of many individuals, particularly those who are vulnerable due to underlying health conditions. My daughter, Lowri, who is 26 and suffers from Rett syndrome, is one such individual. Currently battling for her life on a ventilator in the University Hospital of Wales with pneumonia due to RSV, Lowri’s situation exemplifies the dire need for an urgent revision of the RSV vaccine programme.

Despite evidence of repeated respiratory infections, Lowri has not been considered part of an at-risk group for the RSV vaccine. This oversight is concerning given that she is eligible for both flu and COVID vaccines. The recent availability of an RSV vaccine offers a glimmer of hope; however, it has not been made accessible to individuals like Lowri who clearly need it.

Recent studies and statistics underscore the significance of RSV in contributing to hospital admissions, particularly among those with compromised immune systems or chronic health issues. According to the CDC, adults with certain risk factors are more likely to experience severe outcomes if infected with RSV, yet current guidelines do not adequately encompass this population.

We are calling on health authorities and policymakers to review and extend the RSV vaccine eligibility to include adults with severe disabilities or underlying health conditions. It is crucial that this vaccine programme be inclusive, recognizing the broad spectrum of vulnerable individuals who should be offered protection.

The emotional and physical toll on families caring for loved ones in critical condition due to preventable illness is immense. An updated, broader vaccine programme will not only save lives but also ease the strain on healthcare systems overwhelmed by preventable admissions.

Please sign this petition to urge the responsible health authorities to take immediate action in revising the RSV vaccine programme. Let's protect the health of our most vulnerable before it’s too late.